A massive concrete piling was signed today by the major partners of the Louisiana Cancer Research Consortium, Louisiana State University Health Sciences Center, Tulane University Health Sciences Center and Xavier University, along with state and local dignitaries and several cancer survivors.
In a recent study by the Tulane University Health Sciences Center, it was revealed that using the PAL technique leads to 30% more fat removal as compared to manual liposuction.
Professor of Medicine and Pharmacology and Tullis Tulane Alumni Chair in Diabetes at Tulane University Health Sciences Center, in New Orleans, LA, the Journal covers a range of topics including insulin resistance, central obesity, glucose intolerance, dyslipidemia with elevated triglycerides, predominance of small dense LDL-cholesterol particles, hypertension, endothelial dysfunction, and oxidative stress and inflammation.
Professor of Medicine and Pharmacology and Tullis Tulane Alumni Chair in Diabetes at Tulane University Health Sciences Center, in New Orleans, LA Metabolic Syndrome and Related Disorders is the only peer-reviewed journal to focus solely on the pathophysiology, recognition, and treatment of metabolic syndrome.
Professor of Medicine and Pharmacology and Tullis Tulane Alumni Chair in Diabetes at Tulane University Health Sciences Center, in New Orleans, LA, the Journal covers a range of topics including insulin resistance, central obesity, glucose intolerance, dyslipidemia with elevated triglycerides, predominance of small dense LDL-cholesterol particles, hypertension, endothelial dysfunction, and oxidative stress and inflammation.
The facility is a cooperative partnership among the State of Louisiana's Department of Economic Development, Louisiana State University Health Sciences Center, Tulane University Health Sciences Center, Louisiana Gene Therapy Research Consortium and the newly-formed New Orleans BioInnovation Center, Inc.
Diez, Assistant Professor of Medicine, Director Interventional Cardiology Research, and colleagues at Tulane University Health Sciences Center, New Orleans, was presented in the July 2003 issue of the Journal of Invasive Cardiology and further validates the value of PharmaNetics' ENOX test in detecting the anticoagulant effects of enoxaparin in patients who undergo percutaneous coronary intervention (PCI).
